Hostname: page-component-84b7d79bbc-c654p Total loading time: 0 Render date: 2024-08-05T01:12:22.127Z Has data issue: false hasContentIssue false
  • English
  • Français

AIDS: Serologic Testing for the Human Immunodeficiency Virus—To Screen or Not to Screen

Published online by Cambridge University Press:  21 June 2016

Dennis G. Maki
Dennis G. Maki*
Affiliation:
Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, and the Infection Control Department, University of Wisconsin Hospital and Clinics, University of Wisconsin-Madison, Madison, Wisconsin
*
University of Wisconsin Hospital and Clinics—H41574, 600 Highland Avenue, Madison, WI 53792
Get access Rights & Permissions [Opens in a new window]

Extract

The world pandemic of acquired immunodeficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV) is now in its eighth year and may represent the most serious infectious disease threat to world health in modern history. We now have the capability to diagnose HIV infection very accurately by simple serologic means. However, there has been great reluctance in this country to use serologic testing on a wide scale as a weapon in the war against AIDS. It is hard to believe that when serologic testing first became available, there was controversy as to whether blood donors should be routinely screened.

Type
Program Summaries
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 6 , June 1989 , pp. 243 - 247
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Rhame, FS, Maki, DG: The case fix wider use of testing for HIV infection. N Engl J Med 1989; 320: 1248–1254.Google Scholar
2. CDC: Recommendations for prevention of HIV transmission in healthcare settings. MMRW 1987; 36(Suppl 2S): 3S–18S.Google Scholar
3. Jackson, JB. Coombs, RW. Sannerud, K, et al: Rapid and sensitive viral method for human immunodeficiency virus type I. J Clin Microbiol 1988: 26: 1416–1418.Google Scholar
4. Ou, C, Kwok, S, Mitchell, SW. et al: DNA amplification for direct detection of HIV-I in DNA of peripheral blood mononuclear cells. Science 1988; 239: 295–297.CrossRefGoogle ScholarPubMed
5. Burke, DS, Brundage, JF, Redfield, RR. et al: Measurement of the false-positive rate in a screening program for immunodeficiency virus infections. N Engl J Med 1988; 319: 961–964.CrossRefGoogle Scholar
6. McDonald, KL, Jackson, JB, Bowman, RJ. et al: Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors: Public health and clinical implications. Ann Intern Med 1989; 110: 617–621.Google Scholar
7. CDC: Human immunodeficiency virus infection in the United States. A review of current knowledge. MMWR 1987; 36(suppl 5-6): 1–48.Google Scholar
8. Kelen, GD, Fritz, S, Qaqish, Q. et al: Unrecognized human immunodeficiency virus infection in emergency department patients. Engl J Med 1988; 318: 1645–1650.Google Scholar
9. Novick, LF, Berns, D. Strieof, R. et al: HIV seroprevalence in newborns in New York state. JAMA 1989; 261: 1745–1750.CrossRefGoogle ScholarPubMed
10. Hoff, RH, Berardi, VP, Weiblen, BJ. et al: Seraprevalence of human immunodeficiency virus among child bearing women. N Engl J Med 1988; 318: 525–530 CrossRefGoogle Scholar
11. Selwyn, PA. Hartel, D, Lewis, VA. et al: A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989: 320: 545–550.Google Scholar
12. Weiss, R. Thier, SO: HIV testing is the answer—What's the question? N Engl J Med 1988; 319: 1010–1012.Google Scholar
13. Kates W, Jr. Handsfield, HH: HIV counseling and testing: Does it work? Am J Public Health 1988: 78: 1533–1534.Google Scholar
14. CDC: Prevention of perinatal transmission of hepatitis B virus: Prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR 1988; 37: 341-346, 351.Google Scholar
15. Maki, DC: Perspective HIV testing. The surgeon's right to know: Testing deserves to be tested. Presented at the annual meeting of the Infectious Diseases Society of America. Los Angeles. October 27-28, 1988.Google Scholar